Brn-5, a member of the POU domain transcription factor family, is a critical regulator of neural development and differentiation. It acts as a transcription factor, exerting control over the expression of genes involved in neuronal specification, cell fate determination, and synaptic connectivity. Through its interactions with specific DNA sequences and cofactor proteins, Brn-5 orchestrates the complex transcriptional programs that underlie neural patterning and differentiation processes during embryonic development and postnatal neurogenesis.
Inhibition of Brn-5 involves targeting its transcriptional regulatory functions and disrupting the signaling pathways that control its expression and activity. Various chemicals act as direct inhibitors of Brn-5 by interfering with its transcriptional activation or repression mechanisms. For instance, compounds like Trichostatin A and Curcumin modulate chromatin accessibility and histone modifications, leading to altered transcriptional regulation of Brn-5 target genes. Similarly, inhibitors of key signaling pathways, such as PI3K/Akt signaling targeted by LY294002 and Wortmannin, can indirectly suppress Brn-5 expression by affecting its transcriptional activation pathways. Overall, understanding the molecular mechanisms of Brn-5 inhibition provides insights into its role in neural development and offers strategies for modulating neurogenesis and neuronal function in health and disease.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin inhibits NF-κB signaling, suppressing the expression of Brn-5 by interfering with its transcriptional regulation. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Fluorouracil inhibits thymidylate synthase, disrupting nucleotide synthesis and leading to down-regulation of Brn-5 expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA, preventing transcription initiation and leading to the inhibition of Brn-5 expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis, resulting in decreased expression of Brn-5 due to reduced translation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K/Akt signaling, down-regulating Brn-5 expression by affecting its transcriptional activation pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits PI3K/Akt signaling, leading to decreased phosphorylation and activity of transcription factors regulating Brn-5. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide inhibits SIRT1, altering histone deacetylation patterns and thereby suppressing Brn-5 transcription. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol inhibits SIRT1, impacting histone deacetylation and leading to transcriptional repression of Brn-5. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to GC-rich DNA sequences, interfering with transcriptional regulation and suppressing Brn-5 expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin inhibits RNA polymerase II, hindering transcriptional elongation and consequently suppressing Brn-5 mRNA synthesis. | ||||||